P1.01-68 Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status with Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients
暂无分享,去创建一个
S. Novello | D. Planchard | M. Hellmann | L. Paz-Ares | A. Dingemans | B. Besse | G. Lopes | L. Mezquita | E. Nadal | L. Hendriks | G. Numico | D. Saravia | W. Park | E. Auclin | I. Sullivan | J. Adam | Gérard Zalcman | Kathryn Cecilia Arbour | S. Ponce Aix | Clarisse Audigier-Valette | Simona Carnio | Jose Carlos Ruffinelli